| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Michael Berk | Q30504747 |
| Buranee Kanchanatawan | Q96233092 | ||
| Nathan Dowling | Q96250734 | ||
| Lesley Berk | Q58456831 | ||
| Melanie Maree Ashton | Q60473818 | ||
| Gin Malhi | Q89872646 | ||
| P2093 | author name string | Michael Maes | |
| Atapol Sughondhabirom | |||
| Chee Ng | |||
| Olivia May Dean | |||
| Sookjareon Tangwongchai | |||
| P2860 | cites work | Minocycline: therapeutic potential in psychiatry | Q22241418 |
| A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia | Q28263942 | ||
| Altered expression of neurotrophic factors in patients with major depression | Q28271088 | ||
| Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. | Q51984734 | ||
| Lower serum vitamin E concentrations in major depression | Q56767310 | ||
| Possible antidepressant effect of minocycline | Q70996349 | ||
| Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients | Q74349181 | ||
| A novel target of action of minocycline in NGF-induced neurite outgrowth in PC12 cells: translation initiation [corrected] factor eIF4AI. | Q33769000 | ||
| Minocycline is cytoprotective in human trabecular meshwork cells and optic nerve head astrocytes by increasing expression of XIAP, survivin, and Bcl-2 | Q34019667 | ||
| Clinical relevance of the neurotrophins and their receptors | Q34484451 | ||
| Minocycline attenuates hyperlocomotion and prepulse inhibition deficits in mice after administration of the NMDA receptor antagonist dizocilpine. | Q34574117 | ||
| The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression | Q34904703 | ||
| Antidepressant drugs and cytokines in mood disorders | Q35018733 | ||
| Cytokines and major depression | Q36031971 | ||
| Does minocycline have antidepressant effect? | Q37082204 | ||
| The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity | Q37699054 | ||
| Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors | Q37799094 | ||
| A study on the mechanisms by which minocycline protects against MDMA ('ecstasy')-induced neurotoxicity of 5-HT cortical neurons | Q40379051 | ||
| Inhibitory action of minocycline on lipopolysaccharide-induced release of nitric oxide and prostaglandin E2 in BV2 microglial cells | Q40565950 | ||
| Increased autoimmune responses against auto-epitopes modified by oxidative and nitrosative damage in depression: implications for the pathways to chronic depression and neuroprogression | Q42716476 | ||
| Blockade of acute microglial activation by minocycline promotes neuroprotection and reduces locomotor hyperactivity after closed head injury in mice: a twelve-week follow-up study. | Q43157808 | ||
| Mitochondria and calcium flux as targets of neuroprotection caused by minocycline in cerebellar granule cells. | Q43291649 | ||
| Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments | Q43568192 | ||
| Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors | Q44773988 | ||
| Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression | Q44945159 | ||
| Escitalopram dose-response revisited: an alternative psychometric approach to evaluate clinical effects of escitalopram compared to citalopram and placebo in patients with major depression | Q45024354 | ||
| Minocycline effects on cerebral edema: relations with inflammatory and oxidative stress markers following traumatic brain injury in mice. | Q45920274 | ||
| Reduced neurogenesis after suppressed inflammation by minocycline in transient cerebral ischemia in rat. | Q46137586 | ||
| Chronic treatment with minocycline preserves adult new neurons and reduces functional impairment after focal cerebral ischemia | Q46253405 | ||
| Minocycline as adjunctive therapy for schizophrenia: an open-label study | Q46330964 | ||
| Behavioral responses during the forced swim test are not affected by anti-inflammatory agents or acute illness induced by lipopolysaccharide | Q46442760 | ||
| Minocycline inhibits oxidative stress and decreases in vitro and in vivo ischemic neuronal damage | Q46464808 | ||
| Desipramine or glutamate antagonists synergized the antidepressant-like actions of intra-nucleus accumbens infusions of minocycline in male Wistar rats | Q46474101 | ||
| Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity | Q46484407 | ||
| Protective effect of minocycline, a semi-synthetic second-generation tetracycline against 3-nitropropionic acid (3-NP)-induced neurotoxicity | Q46829569 | ||
| Increased serum levels of 8-hydroxy-2'-deoxyguanosine in clinical depression | Q46921439 | ||
| Sample size calculations for clinical pharmacology studies | Q47209592 | ||
| Minocycline produced antidepressant-like effects on the learned helplessness rats with alterations in levels of monoamine in the amygdala and no changes in BDNF levels in the hippocampus at baseline. | Q48107443 | ||
| Hydrogen peroxide attenuates insulin-like growth factor-1 neuroprotective effect, prevented by minocycline | Q48155067 | ||
| Possible antipsychotic effects of minocycline in patients with schizophrenia | Q48400463 | ||
| Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine. | Q48472593 | ||
| The expression of genes encoding for COX-2, MPO, iNOS, and sPLA2-IIA in patients with recurrent depressive disorder. | Q48732134 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P921 | main subject | major depressive disorder | Q42844 |
| placebo | Q269829 | ||
| minocycline | Q415336 | ||
| P304 | page(s) | 180-188 | |
| P577 | publication date | 2014-12-26 | |
| P1433 | published in | Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology | Q26842559 |
| P1476 | title | Protocol and rationale-the efficacy of minocycline as an adjunctive treatment for major depressive disorder: a double blind, randomised, placebo controlled trial | |
| P478 | volume | 12 |
| Q64078160 | Abnormalities in Inflammatory Cytokines Confer Susceptible to Chronic Neuropathic Pain-related Anhedonia in a Rat Model of Spared Nerve Injury |
| Q47704592 | Adjunctive minocycline treatment for major depressive disorder: A proof of concept trial. |
| Q60610921 | Anti-inflammatory Agents for the Treatment of Depression in the Light of Comorbid Cardiovascular Disease |
| Q64078190 | Antidepressant-like Effects Induced by Chronic Blockade of the Purinergic 2X7 Receptor through Inhibition of Non-like Receptor Protein 1 Inflammasome in Chronic Unpredictable Mild Stress Model of Depression in Rats |
| Q39183235 | Do Statins Have Antidepressant Effects? |
| Q26798929 | Glia in the cytokine-mediated onset of depression: fine tuning the immune response |
| Q42378870 | Immuno-psychiatry: an agenda for clinical practice and innovative research |
| Q40208014 | Indoleamine-2,3-Dioxygenase/Kynurenine Pathway as a Potential Pharmacological Target to Treat Depression Associated with Diabetes. |
| Q37310533 | Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment. |
| Q37310528 | Inflammation in Depression and the Potential for Anti-Inflammatory Treatment |
| Q47745353 | Inflammatory Mediators in Mood Disorders: Therapeutic Opportunities |
| Q34549390 | Investigational drugs in recent clinical trials for treatment-resistant depression |
| Q47559443 | Multiple Immune-Inflammatory and Oxidative and Nitrosative Stress Pathways Explain the Frequent Presence of Depression in Multiple Sclerosis. |
| Q92212858 | Personality disorder and functioning in major depressive disorder: a nested study within a randomized controlled trial |
| Q38885617 | Role of Inflammation in Suicide: From Mechanisms to Treatment |
| Q36253980 | The Gut-Brain Axis in Healthy Females: Lack of Significant Association between Microbial Composition and Diversity with Psychiatric Measures |
| Q35819780 | The Microbiome in Mental Health: Potential Contribution of Gut Microbiota in Disease and Pharmacotherapy Management |
| Q35246024 | The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders |
| Q47785792 | Therapeutic strategies for treatment of inflammation-related depression. |
Search more.